Myriam Adi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Nlrp Inflammasome

Top Venues

Molecular pharmaceutics

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Uzair S Ismailani, Ariel Buchler, Nicole MacMullin, Faduma Abdirahman, Myriam Adi, Benjamin H Rotstein
Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis. Molecular pharmaceutics 20 (3) (2023)
Uzair S Ismailani, Ariel Buchler, Nicole MacMullin, Faduma Abdirahman, Myriam Adi, Benjamin H Rotstein
Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis. Molecular pharmaceutics (2023)
Uzair S Ismailani, Ariel Buchler, Nicole MacMullin, Faduma Abdirahman, Myriam Adi, Benjamin H Rotstein
Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis. Molecular pharmaceutics 20 (3) (2023)
Ariel Buchler, Uzair S Ismailani, Nicole MacMullin, Faduma Abdirahman, Myriam Adi, Christina Bi, Catherine Jany, Jeffrey W Keillor, Benjamin H Rotstein
Quinazoline-2-Carboxamides as Selective PET Radiotracers for Matrix Metalloproteinase-13 Imaging in Atherosclerosis. Journal of medicinal chemistry (2023)
Uzair S Ismailani, Ariel Buchler, Nicole MacMullin, Faduma Abdirahman, Myriam Adi, Benjamin H Rotstein
Synthesis and Evaluation of [ 11 C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis. Molecular pharmaceutics 20 (3) (2023)